8-K
filed October 13, 2023, 7:59 PM ET
ticker ALBT
CIK 0001630212
other
confidence high
sentiment neutral
materiality 0.15
Avalon GloboCare shareholders elect directors and approve all proposals at 2023 annual meeting
Avalon GloboCare Corp.
- All 7 director nominees elected, including Wenzhao Lu (5.53M for) and David Jin (5.55M for).
- Ratified Marcum LLP as auditor with 7.22M for, 13.8K against, 32.6K abstain.
- Approved Preferred Share Issuance Proposal (5.52M for, 21.5K against) for conversion of Series A/B Preferred.
- Approved Note Share Issuance Proposal related to May/July 2023 securities purchase agreements (5.52M for).
- Approved Amended 2020 Stock Incentive Plan (5.45M for) and advisory vote on NEO compensation (5.52M for).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Avalon GloboCare Corp. shareholders approved Advisory vote on compensation of named executive officers at the 2023-10-12 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-10-12
Exact text from the filing
FOR AGAINST ABSTAIN BROKER NON-VOTES 5,517,897 32,782 6,770 1,707,228
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Avalon GloboCare Corp. shareholders approved Approve the Note Share Issuance Proposal (potential issuance of shares pursuant to May and July securities purchase agreements, notes, and warrants) at the 2023-10-12 meeting.
- Outcome
- passed
- Meeting
- 2023-10-12
Exact text from the filing
FOR AGAINST ABSTAIN BROKER NON-VOTES 5,518,830 20,888 17,731 1,707,228
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Avalon GloboCare Corp. shareholders approved Election of seven directors at the 2023-10-12 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-10-12
Exact text from the filing
FOR WITHHELD BROKER NON-VOTES Wenzhao Lu 5,528,621 28,828 1,707,228 David Jin, MD, PhD 5,550,026 7,423 1,707,228 Steven A. Sanders 5,503,532 53,917 1,707,228 Lourdes Felix 5,525,718 31,731 1,707,228 Wilbert J. Tauzin II 5,530,783 26,666 1,707,228 William B. Stilley, III 5,502,958 54,491 1,707,228 Tevi Troy 5,503,496 53,953 1,707,228
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Avalon GloboCare Corp. shareholders approved Advisory vote on frequency of future advisory votes on executive compensation at the 2023-10-12 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-10-12
Exact text from the filing
ONE YEAR TWO YEARS THREE YEARS ABSTAIN BROKER NON-VOTES 5,529,740 21,533 3,545 2,631 1,707,228
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Avalon GloboCare Corp. shareholders approved Approve the Amended and Restated 2020 Stock Incentive Plan (Plan Proposal) at the 2023-10-12 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-10-12
Exact text from the filing
FOR AGAINST ABSTAIN BROKER NON-VOTES 5,451,360 87,665 18,424 1,707,228
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Avalon GloboCare Corp. shareholders approved Ratify the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-10-12 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-10-12
Exact text from the filing
FOR AGAINST ABSTAIN BROKER NON-VOTES 7,218,220 13,827 32,630 N/A
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Avalon GloboCare Corp. shareholders approved Approve the Preferred Share Issuance Proposal (potential issuance of shares upon conversion of Series A and Series B Convertible Preferred Stock in connection with acquisition of Laboratory Services MSO, LLC) at the 2023-10-12 meeting.
- Outcome
- passed
- Meeting
- 2023-10-12
Exact text from the filing
FOR AGAINST ABSTAIN BROKER NON-VOTES 5,518,824 21,487 17,138 1,707,228
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.